Advances in paediatric neuropsychopharmacology: An overview

International Journal of Neuropsychopharmacology

Volumn 4, Issue 2, 2001, Pages 141-147

  March, John S ^a,c   Vitiello, Benedetto ^b  

^a DUKE UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adolescent; Child; Diagnosis; Neuropsychopharmacology; NIMH; PANDAS; Treatment

Indexed keywords

METHYLPHENIDATE;

AUTOIMMUNE DISEASE; COMPULSION; DEPRESSION; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; NEUROPHARMACOLOGY; OBSESSION; PANIC; PEDIATRICS; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; SLEEP DISORDER;

ADOLESCENT; AUTOIMMUNITY; CHILD; DEPRESSIVE DISORDER, MAJOR; HUMANS; MENTAL DISORDERS; NATIONAL INSTITUTES OF HEALTH (U.S.); NEUROPHARMACOLOGY; OBSESSIVE-COMPULSIVE DISORDER; PANIC DISORDER; PEDIATRICS; PSYCHOPHARMACOLOGY; PSYCHOTROPIC DRUGS; SLEEP DISORDERS; STREPTOCOCCAL INFECTIONS; UNITED STATES;

EID: 0034956525     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145701002346     Document Type: Review

References (58)

1. Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: Pharmacokinetics, tolerability, and efficacy
2. Comorbidity
3. NIMH Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design, methodology and protocol evolution
4. Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: A prospective 6-month study
5. Biological studies in depressed children and adolescents
6. Targeted prevention of unipolar depressive disorder in an at-risk sample of high school adolescents: A randomized trial of a group cognitive intervention
7. Sleep polysomnography as a predictor of recurrence in children and adolescents with major depressive disorder
8. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in paediatric patients: Final rule
9. Age and age at onset in paediatric OCD
10. Pandas: The search for environmental triggers of paediatric neuropsychiatric disorders. Lessons from rheumatic fever
11. A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections
12. Festschrift. Joaquim Puig-Antich MD (1944-1989)
13. Relationship of body size and body mass to blood pressure: Sex-specific and developmental influences
14. Heart rate variability in depressive and anxiety disorders
15. Stimulant medications
16. Correlations between motor persistence and plasma levels in methylphenidate -treated boys with ADHD
17. Prevention and early intervention for depression in adolescence and early adult life
18. Introduction to the special section: Efficacy and effectiveness in studies of child and adolescent psychotherapy
19. The millennium of mind, brain, and behavior
20. Fact versus fancy concerning the multimodal treatment study for attention-deficit hyperactivity disorder
21. Psychoactive medication prescribing practices for U.S. children: Gaps between research and clinical practice
22. Psychoactive medication prescribing practices for U.S. children: Gaps between research and clinical practice
23. Pharmacokinetics and clinical effectiveness of methylphenidate
24. Tourette's Syndrome and 'Pandas': Will the relation bear out? Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection
25. Regulatory issues in paediatric psychopharmacology
26. Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents
27. Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS)
28. Child psychiatry: Cognitive and behavior therapies
29. Obsessive-compulsive disorder: A review of the past ten years
30. Neuropsychiatry of paediatric obsessive compulsive disorder
31. Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA)
32. Predicting the outcome of treatment
33. Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation
34. Enhanced stress reactivity in paediatric anxiety disorders: Implications for future cardiovascular health
35. A 14-month randomized clinical trial of treatment strategies for attention-deficit /hyperactivity disorder. Multimodal Treatment Study of Children with ADHD
36. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: The multimodal treatment study of children with attention-deficit/hyperactivity disorder
37. Advances in understanding and treating mental illness: Implications for policy
38. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood
39. Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive-compulsive, and attention deficit/hyperactivity disorders
40. Childhood anxiety: Integrating developmental psychopathology and affective neuroscience
41. A. E. Bennett Research Award. Toward a neurodevelopmental model of obsessive-compulsive disorder
42. Brain anatomy and chemistry may predict treatment response in paediatric obsessive-compulsive disorder
43. Prevention of children's psychosocial disorders: Myth and substance
44. The Emanuel Miller Memorial Lecture 1995. Autism: Two-way interplay between research and clinical work
45. Effect of stimulant medication on hyperactive children: A review of reviews
46. Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children
47. Immune mechanisms in paediatric neuropsychiatric disorders. Tourette's Syndrome, Ocd, and Pandas
48. Pediatric psychopharmacology and the interaction between drugs and the developing brain
49. Developmental perspectives in pediatric psychopharmacology
50. Medication development and testing in children and adolescents. Current problems, future directions
51. Prenatal teratogens and the development of adult mental illness
52. The epidemiology of obsessive-compulsive disorder in children and adolescents
53. Obsessive-compulsive disorder with and without tics in an epidemiological sample of adolescents